{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:44:52Z","timestamp":1787237092318,"version":"build-2736575974"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.cld.2008.02.009","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T06:00:23Z","timestamp":1210312823000},"page":"261-276","source":"Crossref","is-referenced-by-count":72,"title":["Antimitochondrial Antibodies and Other Antibodies in Primary Biliary Cirrhosis: Diagnostic and Prognostic Value"],"prefix":"10.1016","volume":"12","author":[{"given":"Luigi","family":"Muratori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Granito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco B.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2008.02.009_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"285","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.009_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1089-3261(03)00104-1","article-title":"Antimitochondrial and other autoantibodies","volume":"7","author":"Bogdanos","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2008.02.009_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2008.02.009_bib4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(82)91327-7","article-title":"ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis","volume":"320","author":"Berg","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.009_bib5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.1840050510","article-title":"Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen","volume":"5","author":"Lindenborn-Fotinos","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000171347","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance","volume":"10","author":"Berg","year":"1992","journal-title":"Dig Dis"},{"key":"10.1016\/j.cld.2008.02.009_bib7","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.4049\/jimmunol.135.3.1739","article-title":"Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens","volume":"135","author":"Frazer","year":"1985","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib8","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib9","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1073\/pnas.85.22.8654","article-title":"Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis","volume":"85","author":"Fussey","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2008.02.009_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2005-916325","article-title":"The immune response to mitochondrial autoantigens","volume":"25","author":"Ishibashi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2008.02.009_bib11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2003.09.034","article-title":"Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis","volume":"125","author":"Bruggraber","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.009_bib12","first-page":"331","article-title":"Microsomal antibodies in active chronic hepatitis and other disorders","volume":"15","author":"Rizzetto","year":"1973","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.009_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cld.2008.02.009_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2008.02.009_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"\u2018True\u2019 antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dld.2004.09.019","article-title":"The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis","volume":"37","author":"Muratori","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2008.02.009_bib20","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/0016-5085(90)90488-M","article-title":"Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression","volume":"99","author":"Heseltine","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.009_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for\u00a0three different lipoyl domain for the detection of antimitochondrial autoantibodies","volume":"24","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhep.2001.26514","article-title":"Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens","volume":"34","author":"Miyakawa","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10875-007-9092-0","article-title":"Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis","volume":"27","author":"Gabeta","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib25","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib26","first-page":"288","article-title":"Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis","volume":"3","author":"Zhang","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.cld.2008.02.009_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.510260103","article-title":"Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation","volume":"26","author":"Kim","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.009_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","article-title":"Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis","volume":"94","author":"Springer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.009_bib31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.009_bib32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.009_bib33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510250103","article-title":"Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression","volume":"25","author":"Van Norstrand","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0168-8278(91)90903-O","article-title":"Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6-18 years","volume":"12","author":"Klein","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.009_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0676.1997.tb00793.x","article-title":"Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years","volume":"17","author":"Klein","year":"1997","journal-title":"Liver"},{"key":"10.1016\/j.cld.2008.02.009_bib37","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1572-0241.2002.05620.x","article-title":"Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?","volume":"97","author":"Joshi","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.009_bib38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1023\/A:1023055714208","article-title":"Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis","volume":"48","author":"Masuda","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2008.02.009_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/08916930600633006","article-title":"IgA class antibodies to 2-oxo-acid dehydrogenase complex are not predictive markers of histopathological progression in primary biliary cirrhosis","volume":"39","author":"Omagari","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cld.2008.02.009_bib40","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1699-0463.1998.tb00235.x","article-title":"Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology","volume":"106","author":"Kisand","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.cld.2008.02.009_bib41","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","article-title":"Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis","volume":"27","author":"Rigopoulou","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2008.02.009_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cca.2007.01.023","article-title":"Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis","volume":"380","author":"Rigopoulou","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cld.2008.02.009_bib43","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1111\/j.1572-0241.1999.01380.x","article-title":"Is there a serological difference between men and women with primary biliary cirrhosis?","volume":"94","author":"Nalbandian","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.009_bib44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/qjmed\/hcm059","article-title":"Clinical and serological profile of primary biliary cirrhosis in men","volume":"100","author":"Muratori","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.cld.2008.02.009_bib45","first-page":"237","article-title":"Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications","volume":"1","author":"Doniach","year":"1966","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib46","first-page":"553","article-title":"Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis","volume":"55","author":"Bernstein","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0676.1984.tb00918.x","article-title":"Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease","volume":"4","author":"Kurki","year":"1984","journal-title":"Liver"},{"key":"10.1016\/j.cld.2008.02.009_bib48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.009_bib49","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.41.6.612","article-title":"Anticentromere antibody in primary biliary cirrhosis","volume":"41","author":"Bernstein","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cld.2008.02.009_bib50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1440-1746.1995.tb01597.x","article-title":"High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities","volume":"10","author":"Parveen","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.009_bib51","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.145.12.4338","article-title":"Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis","volume":"145","author":"Szostecki","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-3083.1992.tb03224.x","article-title":"Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution","volume":"36","author":"Szostecki","year":"1992","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-3083.1995.tb03652.x","article-title":"Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis","volume":"42","author":"Sternsdorf","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-1007184","article-title":"Autoantibodies against \u201cnuclear dots\u201d in primary biliary cirrhosis","volume":"17","author":"Szostecki","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2008.02.009_bib55","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.1840080438","article-title":"Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis","volume":"8","author":"Lozano","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib56","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1084\/jem.182.4.1159","article-title":"Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210","volume":"182","author":"Wesierska-Gadek","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cld.2008.02.009_bib57","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/gast.1996.v110.pm8608894","article-title":"Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis","volume":"110","author":"Wesierska-Gadek","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.009_bib58","doi-asserted-by":"crossref","first-page":"11306","DOI":"10.1016\/S0021-9258(19)78126-5","article-title":"Primary structure analysis and lamin B and DNA binding of human LBR, an integral protein of the nuclear envelope inner membrane","volume":"269","author":"Ye","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cld.2008.02.009_bib59","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.172.3.961","article-title":"Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis","volume":"172","author":"Courvalin","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.cld.2008.02.009_bib60","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.009_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2172-7-20","article-title":"Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence","volume":"7","author":"Tsiakalou","year":"2006","journal-title":"BMC Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(94)95333-3","article-title":"Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis","volume":"106","author":"Nickowitz","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.009_bib63","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(00)00040-4","article-title":"Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis","volume":"34","author":"Invernizzi","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.009_bib64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2249.2002.01719.x","article-title":"Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders","volume":"127","author":"Muratori","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.2003.07270.x","article-title":"Positive markers in AMA-negative PBC","volume":"98","author":"Vergani","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.009_bib66","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1365-2036.2006.03172.x","article-title":"Antinuclear antibodies giving the \u2018multiple nuclear dots\u2019 or the \u2018rim-like\/membranous\u2019 patterns: diagnostic accuracy for primary biliary cirrhosis","volume":"24","author":"Granito","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2008.02.009_bib67","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00365529409092488","article-title":"Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome","volume":"29","author":"Dorner","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.009_bib68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2169\/internalmedicine.39.451","article-title":"Clinical, serological and genetic study in patients with CREST syndrome","volume":"39","author":"Akiyama","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.cld.2008.02.009_bib69","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.009_bib70","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2169\/internalmedicine.31.1348","article-title":"Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis","volume":"31","author":"Shoji","year":"1992","journal-title":"Intern Med"},{"key":"10.1016\/j.cld.2008.02.009_bib71","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2008.02.009_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.009_bib73","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00033-7","article-title":"Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study","volume":"20","author":"Miyachi","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cld.2008.02.009_bib74","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.20619","article-title":"Small ubiquitin-related modifiers: a novel and independent class of autoantigens in primary biliary cirrhosis","volume":"41","author":"Janka","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2004.02432.x","article-title":"The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence","volume":"136","author":"Ou","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib77","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/jaut.2002.0622","article-title":"Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases","volume":"19","author":"Fida","year":"2002","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cld.2008.02.009_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/clin.1995.1013","article-title":"Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope","volume":"74","author":"Konstantinov","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cld.2008.02.009_bib79","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/jaut.1997.0156","article-title":"Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis","volume":"10","author":"Mattalia","year":"1997","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cld.2008.02.009_bib80","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0168-8278(98)80233-X","article-title":"The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis","volume":"28","author":"Luettig","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2008.02.009_bib81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-8278(98)80220-1","article-title":"Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation","volume":"28","author":"Dubel","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.009_bib82","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01296447","article-title":"Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis","volume":"31","author":"Kenny","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2008.02.009_bib83","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib84","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib85","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11894-001-0042-3","article-title":"Primary biliary cirrhosis with features of autoimmune hepatitis","volume":"3","author":"Heathcote","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cld.2008.02.009_bib87","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \u201coverlap\u201d syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cld.2008.02.009_bib88","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.009_bib89","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","article-title":"Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib90","first-page":"221","article-title":"Antimitochondrial antibodies in patients with chronic graft-versus-host disease","volume":"10","author":"Siegert","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cld.2008.02.009_bib91","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/clim.1998.4666","article-title":"Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation","volume":"91","author":"Quaranta","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cld.2008.02.009_bib92","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.exphem.2005.12.011","article-title":"The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery","volume":"34","author":"Patriarca","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cld.2008.02.009_bib93","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/blood-2006-06-030304","article-title":"Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis","volume":"109","author":"Bellucci","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cld.2008.02.009_bib94","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","article-title":"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis","volume":"46","author":"Leung","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.009_bib95","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2007.05.011","article-title":"The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study","volume":"47","author":"Bernal","year":"2007","journal-title":"J Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T02:46:24Z","timestamp":1684377984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326108000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1089326108000251"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2008.02.009","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}